Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
And Novo Nordisk (NYSE: NVO) stock, down 4.9%, is the victim. Where to invest $1,000 right now? Our analyst team just ...
Roche And Zealand Team Up To Develop Petrelintide
Roche & Zealand join forces on petrelintide, advancing obesity treatments with innovative amylin analogs. Find out why this ...
Contract Pharma7h
Roche, Zealand Pharma Partner to Co-Develop & Co-Commercialize Obesity Therapy
Roche has entered an exclusive collaboration and licensing agreement with Zealand Pharma under which the parties will ...
RHHBY Enters Into a $5.3B Deal With Zealand Pharma for Obesity Drug
Roche RHHBY announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma for an ...
SWI swissinfo.ch10h
Swiss pharma giant Roche partners with Zealand Pharma on new obesity treatment
Roche announced that it has struck an exclusive deal with Denmark's Zealand Pharma to develop and market petrelintide, a new treatment for obesity.
NBC Los Angeles10h
Roche and Zealand Pharma strike $5.3 billion deal for new obesity drug candidate
Swiss pharmaceutical giant Roche said Wednesday that it had struck a deal worth up to $5.3 billion to develop Zealand ...
Roche, Zealand Pharma enter $5.3B license deal for obesity treatment
Roche (RHHBY) is looking to boost its presence in the booming weight-loss market through an exclusive collaboration and ...
Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – BIOA
NEW YORK, NY / ACCESS Newswire / March 10, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn ...
FINAL REMINDER BIOA DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts BioAge Labs, Inc. Investors to Participate in the Class Action Lawsuit
New York, New York-- (Newsfile Corp. - March 10, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ...
CNET4d
GLP-1 Meds Like Ozempic: Know Potential Benefits, Risk Factors and Overdose Info
Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...
Wall Street Journal14d
Eli Lilly Plans to Spend $27 Billion on New U.S. Plants
Drugmaker Eli Lilly plans to build four new manufacturing plants in the U.S., a $27 billion investment that the company expects will create 3,000 high-skilled jobs and employ 10,000 construction ...